RxDoctor Payments DataLook up a doctor →

Eliot Greenberg, MD

Neurology · Princeton, NJNPI 1710929989

Payments from drug & device makers

$91,984in general payments, 2019–2025

Across 645 payments — averaging $142.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$56K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$13K
  • Novartis$9K
  • Corium, LLC$7K
  • AbbVie$1K
  • Biogen$447
  • plus $5K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.112$55,768
Otsuka Pharmaceutical Development & Commercialization, Inc.10$13,320
Novartis99$9,437
Corium, LLC7$6,598
AbbVie(2 entities)99$1,087
Biogen20$447
Lilly USA, LLC18$400
Bristol Myers Squibb19$394
Sunovion Pharmaceuticals Inc.14$291
Neurelis, Inc.19$287
UCB, Inc.16$254
Genentech USA, Inc.13$246
EMD Serono, Inc.17$230
Amgen(2 entities)10$215
Supernus Pharmaceuticals, Inc.16$212
SK Life Science, Inc.13$198
Insightec,inc2$177
Pfizer11$173
Lundbeck LLC10$158
Biohaven Pharmaceuticals, Inc.7$148
E.r. Squibb & Sons, L.L.C.2$135
Amneal Pharmaceuticals LLC9$135
Abbott2$126
Kyowa Kirin, Inc.8$114
Johnson & Johnson10$112
Argenx US, Inc.6$99
AstraZeneca(2 entities)6$89
Acadia Pharmaceuticals Inc6$85
Neurocrine Biosciences, Inc.5$76
Teva Pharmaceuticals USA, Inc.5$75
Otsuka America Pharmaceutical, Inc.4$70
Axsome Therapeutics, Inc.4$66
Impel Pharmaceuticals Inc.3$52
Jazz Pharmaceuticals Inc.3$51
Biohaven Pharmaceutical Holding Company Ltd.3$45
Acorda Therapeutics, Inc3$42
Alnylam Pharmaceuticals Inc.3$40
Microtransponder, Inc.1$36
Cvrx, Inc.2$35
CSL Behring1$33
Amylyx Pharmaceuticals, Inc.2$31
Revance Therapeutics, Inc.2$31
Life Molecular Imaging Ltd2$31
Vanda Pharmaceuticals Inc.2$31
Bausch Health US, LLC2$29
Idorsia Pharmaceuticals US Inc2$28
Catalyst Pharmaceuticals, Inc.1$24
TG Therapeutics, Inc.1$24
Neuropace, Inc.1$23
Azurity Pharmaceuticals, Inc.1$18
Arbor Pharmaceuticals, Inc.1$16
Octapharma USA, Inc.1$16
Sanofi1$15
Avion Pharmaceuticals1$15
Mallinckrodt Hospital Products Inc.1$15
Tonix Medicines, Inc.1$14
Vertical Pharmaceuticals, LLC1$14
Collegium Pharmaceutical, Inc.1$14
Boston Scientific1$14
Greenwich Biosciences, Inc.1$14

How this compares

$91,984 in reported general payments places this provider in the 90th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey

Medicare billing

Part B allowed, 2024
$237,605
Medicare patients
477
Services billed
12,167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →